AiMeD expresses dismay over FICCI’s ‘Un-Make in India’ drive
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
Department and Industry Associations to organize 3 days National Level Expo on Indian Medical Devices Sector at Pragati Maidan, New Delhi between 9-11 Dec 2022, first of its kind expo in India
The total financial outlay of the scheme is Rs.500 crore for a period of five years from 2021-22 to 2025-26.
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
The selected 49 applications are from 33 companies. Out of these 33 companies, 13 are Micro, Small and Medium Enterprises (MSMEs) besides some newly incorporated entities
Collaboration in the industry needs to be institutionalised to drive the growth.
According to the state government, it will also provide support to special projects such as preclinical testing, genome sequencing in the private sector, private sector BSL-3 lab-vaccine development and manufacturing and testing and certification laboratories
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
Subscribe To Our Newsletter & Stay Updated